News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive November 20, 2018 Deciphera Pharmaceuticals, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference Archive November 15, 2018 Deciphera Pharmaceuticals Completes Enrollment in the INVICTUS Pivotal Phase 3 Clinical Study of DCC-2618 in Patients with Advanced Gastrointestinal Stromal Tumors Archive November 8, 2018 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results Archive October 23, 2018 Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors Archive October 19, 2018 Deciphera Pharmaceuticals Reports Updated Preliminary Phase 1 Clinical Study Results with DCC-2618 at the European Society of Medical Oncology (ESMO) 2018 Congress Archive September 25, 2018 Deciphera Pharmaceuticals, Inc. to Present at the 2018 Cantor Global Healthcare Conference Archive September 18, 2018 Deciphera Pharmaceuticals Appoints Daniel C. Martin as Chief Commercial Officer Archive August 29, 2018 Deciphera Pharmaceuticals, Inc. to Participate in Citi’s 13th Annual Biotech Conference Archive August 7, 2018 Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2018 Financial Results Archive August 1, 2018 Deciphera Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference
Archive November 20, 2018 Deciphera Pharmaceuticals, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference
Archive November 15, 2018 Deciphera Pharmaceuticals Completes Enrollment in the INVICTUS Pivotal Phase 3 Clinical Study of DCC-2618 in Patients with Advanced Gastrointestinal Stromal Tumors
Archive November 8, 2018 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results
Archive October 23, 2018 Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
Archive October 19, 2018 Deciphera Pharmaceuticals Reports Updated Preliminary Phase 1 Clinical Study Results with DCC-2618 at the European Society of Medical Oncology (ESMO) 2018 Congress
Archive September 25, 2018 Deciphera Pharmaceuticals, Inc. to Present at the 2018 Cantor Global Healthcare Conference
Archive September 18, 2018 Deciphera Pharmaceuticals Appoints Daniel C. Martin as Chief Commercial Officer
Archive August 29, 2018 Deciphera Pharmaceuticals, Inc. to Participate in Citi’s 13th Annual Biotech Conference
Archive August 7, 2018 Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2018 Financial Results
Archive August 1, 2018 Deciphera Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference
